Postpartum Depression

Postpartum depression (PPD), also called postnatal depression, is a form of clinical depression which can affect women, and less frequently men, typically after childbirth. Studies report prevalence rates among women from 5% to 25%, but methodological differences among the studies make the actual prevalence rate unclear. Among men, in particular new fathers, the incidence of postpartum depression has been estimated to be between 1.2% and 25.5%. Postpartum depression occurs in women after they have carried a child, usually in the first few months, and may last up to several months or even a year. Specifically, the onset of postpartum depression begins within 4 weeks and lasting up to 6 months after giving birth. Symptoms include sadness, fatigue, changes in sleeping and eating patterns, reduced libido, crying episodes, anxiety, and irritability. Although a number of risk factors have been identified, the causes of PPD are not well understood. Many women recover with a treatment consisting of a support group or counseling.

The Edinburgh Postnatal Depression Scale, a standardized self-reported questionnaire, may be used to identify women who have postpartum depression.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

She's not interested in sex but he thinks she is

Imagine the following scenario: a woman and a man are having a conversation. She is interested in the conversation, and is friendly, smiling and warm. He interprets her behavior as sexual interest.

Infants create new knowledge while sleeping

There is no rest for a baby's brain – not even in sleep. While infants sleep they are reprocessing what they have learned. Working with researchers from the University of Tübingen, scientists from the ...

Researchers design tailored tissue adhesives

After undergoing surgery to remove diseased sections of the colon, up to 30 percent of patients experience leakage from their sutures, which can cause life-threatening complications.

Scientists develop compound to fight MRSA

Microbiologists and chemists at the University of South Florida have developed and patented a synthetic compound that has shown antibiotic action against methicillin resistant Staphylococcus aureus, also k ...